Fidaxomicin
3 NDCs across 3 manufacturers|2 Generic,1 Brand
Fidaxomicin is used to treat pseudomembranous enterocolitis, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved on May 27, 2011, and the first generic was approved Jan 16, 2024. FDA's Orange Book lists 5 AB-rated (therapeutically equivalent) products for this ingredient. In 2024, Medicare Part D spent $154 million on Fidaxomicin across 35,000 claims for 26,000 beneficiaries.
Fidaxomicin is available as 3 NDCs from 3 manufacturers (2 generic, 1 brand), with NADAC prices from $90.50 to $248.38 per EA — the most expensive product costs about 2.7× the cheapest. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
3
2G / 1B
Manufacturers
3
competing in market
Price Spread
$90.50 – $248.38
per EA
7d Activity
avg -3.2% WoW · of 3 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Explore this market from other angles
Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.
Top supplier
Merck Sharp & Dohme LLC manufacturer profile
Open the supplier page for the manufacturer with the strongest footprint in this market.
Trend hub
Latest market trends
Move from this single molecule into the current cross-market mover and volatility view.
Guide
How to interpret NADAC
Review the benchmark methodology behind the prices and spreads shown on this market page.
Manufacturer Breakdown
3 manufacturers producing FIDAXOMICIN
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
DIFICID 200 MG TABLET | $248.3785 per EA | -0.03% |
FIDAXOMICIN 200 MG TABLET | $90.5046 per EA | -4.76% |
FIDAXOMICIN 200 MG TABLET | $90.5046 per EA | -4.76% |
Frequently Asked Questions
What is Fidaxomicin used to treat?
Fidaxomicin is used to treat pseudomembranous enterocolitis, per the National Library of Medicine's MED-RT classification.
When did Fidaxomicin become available as a generic?
FDA approved the first generic Fidaxomicin (ANDA) on Jan 16, 2024. The Orange Book currently lists 5 AB-rated products for this ingredient, meaning FDA considers them therapeutically equivalent to the brand.
How much does Medicare spend on Fidaxomicin?
In 2024, Medicare Part D spent $154 million on Fidaxomicin across 35,000 claims for 26,000 beneficiaries.
How many Fidaxomicin products are on the market?
The Fidaxomicin drug market contains 3 NDCs from 3 manufacturers — 2 generic and 1 brand product.
What is the price range for Fidaxomicin?
NADAC reference prices for Fidaxomicin range from $90.5046 to $248.3785 per EA — the most expensive product costs about 2.7× the cheapest.
Is generic Fidaxomicin cheaper than brand?
The average generic NADAC for Fidaxomicin is $90.5046 per EA, versus $248.3785 for brand-labeled products — brand versions average about 2.7× the generic price.
Which manufacturers make Fidaxomicin?
3 manufacturers list Fidaxomicin in NADAC. Ranked by number of NDCs, the largest are Merck Sharp & Dohme LLC (1), Teva Pharmaceuticals USA Inc. (1), Apotex Corp. (1).
How has the price of Fidaxomicin changed recently?
Over the past 7 days, 0 Fidaxomicin NDCs rose and 3 fell, with a market-wide average change of -3.2%.